ClinicalTrials.Veeva

Menu
C

Charlotte Gastroenterology and Hepatology | Randolph Road Office

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

ABT-494
Upadacitinib
Adalimumab
Vonoprazan
Prochymal®
Dehydroepiandrosterone
CP-690,550
Asimadoline
CNI-1493
Guselkumab

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 24 total trials

A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease (GALAXI)

The purpose of this study is to evaluate the clinical efficacy (GALAXI 1), clinical and endoscopic efficacy (GALAXI 2 and GALAXI 3) and safety of gus...

Active, not recruiting
Crohn's Disease
Drug: Ustekinumab
Drug: Guselkumab Dose 3

This study is designed to evaluate the long-term safety and efficacy of Upadacitinib in participants with ulcerative colitis (UC) who have not respon...

Active, not recruiting
Ulcerative Colitis (UC)
Drug: Placebo
Drug: Upadacitinib (ABT-494)

Trial sponsors

AbbVie logo
Abbott logo
Janssen (J&J Innovative Medicine) logo
Mesoblast logo
Pfizer logo
Dartmouth Health logo
E
Exact Sciences Corporation logo
Ferring logo
I

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems